DNA ligase III antibody [1F3]
GTX70143
ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, Neutralisation/Blocking, Other Application
Product group Antibodies
ReactivityChicken, Human, Mouse
TargetLIG3
Overview
- SupplierGeneTex
- Product NameDNA ligase III antibody [1F3] - Orthogonal Validated
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:3000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, Neutralisation/Blocking, Other Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID1F3
- Concentration1 mg/ml
- ConjugateUnconjugated
- Gene ID3980
- Target nameLIG3
- Target descriptionDNA ligase 3
- Target synonymsDNA ligase 3; LIG2; LIG3alpha; ligase II, DNA, ATP-dependent; ligase III, DNA, ATP-dependent; polydeoxyribonucleotide synthase [ATP] 3
- HostMouse
- IsotypeIgG1
- Protein IDP49916
- Protein NameDNA ligase 3
- Scientific DescriptionThis gene is a member of the DNA ligase family. Each member of this family encodes a protein that catalyzes the joining of DNA ends but they each have a distinct role in DNA metabolism. The protein encoded by this gene is involved in excision repair and is located in both the mitochondria and nucleus, with translation initiation from the upstream start codon allowing for transport to the mitochondria and translation initiation from a downstream start codon allowing for transport to the nucleus. Additionally, alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
- ReactivityChicken, Human, Mouse
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- TDP1 suppresses chromosomal translocations and cell death induced by abortive TOP1 activity during gene transcription.Read more
- DePARylation is critical for S phase progression and cell survival.Read more
- Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency.Read more
- WRN regulates pathway choice between classical and alternative non-homologous end joining. Shamanna RA et al., 2016 Dec 6, Nat CommunRead more
- Inhibition of hydrogen sulfide biosynthesis sensitizes lung adenocarcinoma to chemotherapeutic drugs by inhibiting mitochondrial DNA repair and suppressing cellular bioenergetics. Szczesny B et al., 2016 Nov 3, Sci RepRead more
- Base excision repair defects invoke hypersensitivity to PARP inhibition. Horton JK et al., 2014 Aug, Mol Cancer ResRead more
- Effects of chromatin decondensation on alternative NHEJ. Moscariello M et al., 2013 Nov, DNA Repair (Amst)Read more
- Preventing oxidation of cellular XRCC1 affects PARP-mediated DNA damage responses. Horton JK et al., 2013 Sep, DNA Repair (Amst)Read more
- Interaction between DNA Polymerase beta and BRCA1. Masaoka A et al., 2013, PLoS OneRead more
- DNA ligases I and III cooperate in alternative non-homologous end-joining in vertebrates. Paul K et al., 2013, PLoS OneRead more